Ayla Turkar
Research Subjects
Ayla Turkar has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Aylin Babalik
Department of Chest Diseases, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
1 shared publication- Aylin Babalik
Department of Chest Diseases, University of Health Sciences, Süreyyapaşa Training and Research Hospital, Istanbul, Turkey
1 shared publication - Baran Gundogus
Department of Pulmonology, University of Health Sciences, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey
1 shared publication - Elçin Ersöz Köse
Department of Thoracic Surgery, Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital, University of Health Sciences, Istanbul, Türkiye
1 shared publication - Eylem Tuncay
Department of Pulmonology, University of Health Sciences, Sancaktepe Prof. Dr. Ilhan Varank Training and Research Hospital, Istanbul, Turkey
1 shared publication Gorkem Feyzullahoglu
Department of Chest Diseases, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
1 shared publication
Latest Publications
- Open Access
- 23 May 2026
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 26 (1)
Impact of emphysema on biomarkers in hospitalized COPD patients with community-acquired pneumonia: a retrospective study
Background: Chronic obstructive pulmonary disease (COPD) is a heterogeneous disorder in which chronic bronchitis and emphysema coexist to varying degrees. Emphysema has distinct clinical and prognostic features. C-reactive protein (CRP), procalcitonin (PCT), white blood cell count (WBC), and neutrophil values are used for diagnosing community-acquired pneumonia (CAP). This study investigated whether these biomarkers differ in emphysematous patients with CAP. Methods: Patients with COPD hospitalized with CAP between January 2016 and February 2023 were divided into emphysema and non-emphysema groups based on radiologic findings. Emphysema subtypes were classified, and quantitative Goddard scoring was performed. Admission demographic, clinical and laboratory data, hospital stay length and clinical outcomes (discharge, intensive care unit [ICU] transfer, in-hospital mortality) were compared between groups. CRP and PCT levels were dichotomized as low and high using predefined thresholds (CRP ≤ 200 vs. >200 mg/L; PCT < 0.10 vs. ≥0.10 µg/L). The independent effect of emphysema on low CRP and PCT levels was assessed using multivariable binary logistic regression analysis. Results: Of the 135 patients included, 71 (53%) had emphysema. Median CRP and PCT levels were significantly lower in the emphysema group than in the non-emphysema group (CRP: 116, interquartile range [IQR] 56–187 vs. 254 (IQR 213-310 mg/L); p < 0.001; PCT: 0.132 [ IQR 0.079–0.536] vs. 0.356 [IQR 0.171–1.660] µg/L; p = 0.007, respectively). Median WBC and neutrophil counts were also lower ( p = 0.036; p = 0.035, respectively). In multivariable analysis, emphysema (odds ratio [OR] 54.274; 95% Confidence Interval [CI] 14.545–202.526; p < 0.001), higher glomerular filtration rate (OR 1.021; 95% CI 1.002–1.040; p = 0.026), and prior antibiotic use (OR 4.278; 95% CI 1.199–15.264; p = 0.025) were independently associated with low CRP. For low PCT, emphysema remained the only significant predictor (OR 3.694; 95% CI 1.145–11.921; p = 0.029). Length of stay was longer in emphysema (9 vs.7 days; p = 0.010), with no differences in ICU transfer or mortality. Conclusion: In patients with emphysema, inflammatory biomarkers at CAP diagnosis were lower compared with those without emphysema. These findings suggest a potential difference in biomarker response; however, the retrospective design limits causality. Further prospective studies are needed to confirm these results and clarify their clinical relevance. Trial registration: Not applicable. This study is a retrospective observational analysis and was not registered as a clinical trial.
- 23 May 2026
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 26 (1)
Open AccessImpact of emphysema on biomarkers in hospitalized COPD patients with community-acquired pneumonia: a retrospective study
Background: Chronic obstructive pulmonary disease (COPD) is a heterogeneous disorder in which chronic bronchitis and emphysema coexist to varying degrees. Emphysema has distinct clinical and prognostic features. C-reactive protein (CRP), procalcitonin (PCT), white blood cell count (WBC), and neutrophil values are used for diagnosing community-acquired pneumonia (CAP). This study investigated whether these biomarkers differ in emphysematous patients with CAP. Methods: Patients with COPD hospitalized with CAP between January 2016 and February 2023 were divided into emphysema and non-emphysema groups based on radiologic findings. Emphysema subtypes were classified, and quantitative Goddard scoring was performed. Admission demographic, clinical and laboratory data, hospital stay length and clinical outcomes (discharge, intensive care unit [ICU] transfer, in-hospital mortality) were compared between groups. CRP and PCT levels were dichotomized as low and high using predefined thresholds (CRP ≤ 200 vs. >200 mg/L; PCT < 0.10 vs. ≥0.10 µg/L). The independent effect of emphysema on low CRP and PCT levels was assessed using multivariable binary logistic regression analysis. Results: Of the 135 patients included, 71 (53%) had emphysema. Median CRP and PCT levels were significantly lower in the emphysema group than in the non-emphysema group (CRP: 116, interquartile range [IQR] 56–187 vs. 254 (IQR 213-310 mg/L); p < 0.001; PCT: 0.132 [ IQR 0.079–0.536] vs. 0.356 [IQR 0.171–1.660] µg/L; p = 0.007, respectively). Median WBC and neutrophil counts were also lower ( p = 0.036; p = 0.035, respectively). In multivariable analysis, emphysema (odds ratio [OR] 54.274; 95% Confidence Interval [CI] 14.545–202.526; p < 0.001), higher glomerular filtration rate (OR 1.021; 95% CI 1.002–1.040; p = 0.026), and prior antibiotic use (OR 4.278; 95% CI 1.199–15.264; p = 0.025) were independently associated with low CRP. For low PCT, emphysema remained the only significant predictor (OR 3.694; 95% CI 1.145–11.921; p = 0.029). Length of stay was longer in emphysema (9 vs.7 days; p = 0.010), with no differences in ICU transfer or mortality. Conclusion: In patients with emphysema, inflammatory biomarkers at CAP diagnosis were lower compared with those without emphysema. These findings suggest a potential difference in biomarker response; however, the retrospective design limits causality. Further prospective studies are needed to confirm these results and clarify their clinical relevance. Trial registration: Not applicable. This study is a retrospective observational analysis and was not registered as a clinical trial.
- Open Access
- 1 November 2025
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 18, 5703-5710
Comparison of Computed Tomography Findings of Tuberculosis and Non-Tuberculous Mycobacterial Lung Infections
Background: The treatment of non-tuberculous mycobacterial infections, which are becoming increasingly common, is different and longer than tuberculosis. Correct diagnosis and subtyping are vital for patient management. Purpose: To determine the radiological findings of mycobacterial infections, detect differences, and contribute to the most accurate and rapid diagnosis. Materials and Methods: This retrospective and single-center study included a total of 264 patients diagnosed with mycobacterial lung infections, comprising 152 cases of tuberculosis and 112 cases of non-tuberculous mycobacterial infections. Patient demographics (age and gender), the specific subtypes of non-tuberculous mycobacteria, and detailed computed tomography findings were systematically evaluated. Results: Mean age of the patients was 45.84± 16.84 (min 14, max 87). More than half of the mycobacteria infections (54.5%) were in the patient group aged 35– 65. As the patient’s age decreased, the incidence of tuberculosis increased, and as the patient’s age increased, the incidence of non-tuberculous mycobacteria infections increased. 85.9% of patients in the < 35 age group were infected with tuberculosis, and 64.3% of patients in the > 65 age group were infected with non-tuberculous mycobacteria. Male patients were the majority in all mycobacteria infections, but male dominance was especially evident in non-tuberculous mycobacteria infections (p< 0.001 for both). Tree-in-bud and pleural effusion were more common in tuberculosis; while cavity, bronchiectasis, and sequela fibrotic changes were more common in non-tuberculous mycobacteria infections (p< 0.05). The cavitation wall was thicker in tuberculosis (p=0.015). In addition, the anterior segment of the left upper lobe was more frequently affected in tuberculosis patients (p=0.018). Conclusion: It is necessary to know the radiological findings well and to guide clinicians in terms of possible non-tuberculous mycobacterial infection, especially in cases resistant to treatment. Accurate differentiation between tuberculosis and non-tuberculous infections is essential, as it has a direct impact on the treatment algorithm. Multi-center studies with larger patient populations may provide additional contributions to our current knowledge. Plain Language Summary: This study compares lung infections caused by tuberculosis and by non-tuberculous mycobacteria. Although both infections can look similar on CT scans, they are different diseases and require different treatments. To help clinicians tell them apart, we examined CT scan results from 264 patients; 152 with tuberculosis and 112 with non-tuberculous mycobacterial infections. We found that certain features on the CT scans differed between the two groups. By understanding these differences, clinicians can more easily and accurately diagnose the type of infection and select the appropriate treatment. This may help patients receive the correct care more quickly and improve their outcomes.
- 1 November 2025
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 18, 5703-5710
Open AccessComparison of Computed Tomography Findings of Tuberculosis and Non-Tuberculous Mycobacterial Lung Infections
Background: The treatment of non-tuberculous mycobacterial infections, which are becoming increasingly common, is different and longer than tuberculosis. Correct diagnosis and subtyping are vital for patient management. Purpose: To determine the radiological findings of mycobacterial infections, detect differences, and contribute to the most accurate and rapid diagnosis. Materials and Methods: This retrospective and single-center study included a total of 264 patients diagnosed with mycobacterial lung infections, comprising 152 cases of tuberculosis and 112 cases of non-tuberculous mycobacterial infections. Patient demographics (age and gender), the specific subtypes of non-tuberculous mycobacteria, and detailed computed tomography findings were systematically evaluated. Results: Mean age of the patients was 45.84± 16.84 (min 14, max 87). More than half of the mycobacteria infections (54.5%) were in the patient group aged 35– 65. As the patient’s age decreased, the incidence of tuberculosis increased, and as the patient’s age increased, the incidence of non-tuberculous mycobacteria infections increased. 85.9% of patients in the < 35 age group were infected with tuberculosis, and 64.3% of patients in the > 65 age group were infected with non-tuberculous mycobacteria. Male patients were the majority in all mycobacteria infections, but male dominance was especially evident in non-tuberculous mycobacteria infections (p< 0.001 for both). Tree-in-bud and pleural effusion were more common in tuberculosis; while cavity, bronchiectasis, and sequela fibrotic changes were more common in non-tuberculous mycobacteria infections (p< 0.05). The cavitation wall was thicker in tuberculosis (p=0.015). In addition, the anterior segment of the left upper lobe was more frequently affected in tuberculosis patients (p=0.018). Conclusion: It is necessary to know the radiological findings well and to guide clinicians in terms of possible non-tuberculous mycobacterial infection, especially in cases resistant to treatment. Accurate differentiation between tuberculosis and non-tuberculous infections is essential, as it has a direct impact on the treatment algorithm. Multi-center studies with larger patient populations may provide additional contributions to our current knowledge. Plain Language Summary: This study compares lung infections caused by tuberculosis and by non-tuberculous mycobacteria. Although both infections can look similar on CT scans, they are different diseases and require different treatments. To help clinicians tell them apart, we examined CT scan results from 264 patients; 152 with tuberculosis and 112 with non-tuberculous mycobacterial infections. We found that certain features on the CT scans differed between the two groups. By understanding these differences, clinicians can more easily and accurately diagnose the type of infection and select the appropriate treatment. This may help patients receive the correct care more quickly and improve their outcomes.
- 19 March 2025
- Published by SAGE Publications in Acta Radiologica
- Vol. 66 (6) , 666-674
Factors affecting the development of pneumothorax in transthoracic fine-needle aspiration biopsies
Background: Pneumothorax is the most common complication and reason for hospitalization in needle biopsies of lung. Purpose: To investigate the factors that determine the risk and severity of pneumothorax in needle biopsies of lung. Material and Methods: Fine-needle aspiration biopsy was performed for diagnostic purposes in 505 patients under the guidance of computed tomography for lung lesions. Findings were analyzed in terms of demographic characteristics of patients’ and procedure-related features. Results: The mean age of the patients was 65 ± 9.7 years and mean lesion size was 34.31 ± 16.99 mm. Pneumothorax developed in 176 patients. The frequency and severity of pneumothorax were higher in male patients ( P < 0.001 and P = 0.003). Emphysema was a risk factor for pneumothorax ( P = 0.002). The rate of pneumothorax was higher in lower lobe lesions. Pleural length made a significant difference, especially for the severity of pneumothorax. The severity of pneumothorax increased as dwell time increased ( P = 0.029). The need for a chest tube was significantly higher in the group with pneumothorax thickness >1 cm ( P < 0.001). The requirement for multiple passes increased the risk of developing pneumothorax ( P < 0.001). Procedure-related hemorrhage reduced the risk of pneumothorax and prevented the progression of pneumothorax ( P < 0.001 for both). The risk of developing pneumothorax was lowest in the supine position ( P = 0.001). Conclusion: Patient’s sex, presence of emphysema, and lesion location are unchangeable patient-dependent factors for the development of pneumothorax. However, the aim should be to plan the process correctly and complete it with a single entry and a short dwell time.
- 19 March 2025
- Published by SAGE Publications in Acta Radiologica
- Vol. 66 (6) , 666-674
Factors affecting the development of pneumothorax in transthoracic fine-needle aspiration biopsies
Background: Pneumothorax is the most common complication and reason for hospitalization in needle biopsies of lung. Purpose: To investigate the factors that determine the risk and severity of pneumothorax in needle biopsies of lung. Material and Methods: Fine-needle aspiration biopsy was performed for diagnostic purposes in 505 patients under the guidance of computed tomography for lung lesions. Findings were analyzed in terms of demographic characteristics of patients’ and procedure-related features. Results: The mean age of the patients was 65 ± 9.7 years and mean lesion size was 34.31 ± 16.99 mm. Pneumothorax developed in 176 patients. The frequency and severity of pneumothorax were higher in male patients ( P < 0.001 and P = 0.003). Emphysema was a risk factor for pneumothorax ( P = 0.002). The rate of pneumothorax was higher in lower lobe lesions. Pleural length made a significant difference, especially for the severity of pneumothorax. The severity of pneumothorax increased as dwell time increased ( P = 0.029). The need for a chest tube was significantly higher in the group with pneumothorax thickness >1 cm ( P < 0.001). The requirement for multiple passes increased the risk of developing pneumothorax ( P < 0.001). Procedure-related hemorrhage reduced the risk of pneumothorax and prevented the progression of pneumothorax ( P < 0.001 for both). The risk of developing pneumothorax was lowest in the supine position ( P = 0.001). Conclusion: Patient’s sex, presence of emphysema, and lesion location are unchangeable patient-dependent factors for the development of pneumothorax. However, the aim should be to plan the process correctly and complete it with a single entry and a short dwell time.
- Open Access
- 14 March 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (11) , e41823
Relationship between size and other radiological features with malignancy in pulmonary nodules; follow-up or pathological diagnosis?
Pulmonary lesions can be detected even at a few millimeters in size, allowing for detailed assessment of their radiological features. This study aims to determine the most appropriate approach for nodules detected by computed tomography. A total of 526 patients, who underwent surgery for pulmonary nodules or masses and had pathological diagnoses, were included in the study. Demographic features, clinical history, and surgery-related data of the patients were assessed by a thoracic surgeon, whereas radiological features were evaluated by a radiologist. Of the patients, 147 were female and 379 were male. The mean age was 63 years (min 15, max 89), and the average lesion size was 22 mm (min 4, max 116). Postoperative analysis revealed 132 benign lesions (25.1%), 380 malignant (72.2%), and 14 metastases (2.7%). Among 347 patients, the nodule size was below 30 mm. Malignant nodules showed a higher median age and larger lesion size ( P < .05 for both). Lesion contour, calcification, pleural tail, changes in lesion during follow-up, presence of emphysema, enlarged lymph nodes, history of malignancy, and smoking were statistically significant in determining the nature of the detected lesion. The clinical and radiological characteristics of patients can be utilized to determine the risk of malignancy in detected nodules. Even if the nodule size is small, histopathological diagnosis may be a more suitable option for high-risk patients instead of radiological follow-up.
- 14 March 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (11) , e41823
Open AccessRelationship between size and other radiological features with malignancy in pulmonary nodules; follow-up or pathological diagnosis?
Pulmonary lesions can be detected even at a few millimeters in size, allowing for detailed assessment of their radiological features. This study aims to determine the most appropriate approach for nodules detected by computed tomography. A total of 526 patients, who underwent surgery for pulmonary nodules or masses and had pathological diagnoses, were included in the study. Demographic features, clinical history, and surgery-related data of the patients were assessed by a thoracic surgeon, whereas radiological features were evaluated by a radiologist. Of the patients, 147 were female and 379 were male. The mean age was 63 years (min 15, max 89), and the average lesion size was 22 mm (min 4, max 116). Postoperative analysis revealed 132 benign lesions (25.1%), 380 malignant (72.2%), and 14 metastases (2.7%). Among 347 patients, the nodule size was below 30 mm. Malignant nodules showed a higher median age and larger lesion size ( P < .05 for both). Lesion contour, calcification, pleural tail, changes in lesion during follow-up, presence of emphysema, enlarged lymph nodes, history of malignancy, and smoking were statistically significant in determining the nature of the detected lesion. The clinical and radiological characteristics of patients can be utilized to determine the risk of malignancy in detected nodules. Even if the nodule size is small, histopathological diagnosis may be a more suitable option for high-risk patients instead of radiological follow-up.
- 1 January 2024
- Published by Wolters Kluwer Health in International Journal of Mycobacteriology
- Vol. 13 (1) , 40-46
Comparison of Computed Tomography Findings in Lung Tuberculosis in Diabetic and Nondiabetic Patients
Background: Tuberculosis (TB) is one of the leading infectious causes of mortality globally. The purpose of this research is to examine the clinical and radiological characteristics of patients with TB and diabetes. Methods: The research comprised 276 TB patients, 52 of whom were diabetic and 224 of whom were not. During the evaluation of the patients’ clinical histories, age, gender, diagnostic indicator, and whether or not they had undergone prior treatment were questioned, as were the requirement of inpatient treatment and the existence of drug resistance. Radiographically, they were questioned in terms of bilateral–unilateral extent, percentage of parenchymal involvement, cavitation, tree-in-bud appearance, the presence of ground glass, consolidation, miliary involvement, sequela fibrotic changes, parenchymal calcification, mediastinal lymphadenopathy, pleural effusion, and pleural calcification. In addition, segmenting was used to assess involvement in the affected lobes. Results: When we look at the results of 276 patients, 182 males and 94 females, the mean age is 46.01 ± 17.83. Diabetes and TB coexistence are more prevalent in male individuals (P = 0.029). Smear positivity and the need for inpatient treatment were found to be higher in the clinical features of diabetic patients (P = 0.05 and P = 0.01, respectively). Radiologically, diabetes individuals are more likely to have larger mediastinal lymph nodes (P = 0.032). Conclusion: In the coexistence of both TB and diabetes, there are variations in radiological findings, complexity in treatment response, and patient management.
- 1 January 2024
- Published by Wolters Kluwer Health in International Journal of Mycobacteriology
- Vol. 13 (1) , 40-46
Comparison of Computed Tomography Findings in Lung Tuberculosis in Diabetic and Nondiabetic Patients
Background: Tuberculosis (TB) is one of the leading infectious causes of mortality globally. The purpose of this research is to examine the clinical and radiological characteristics of patients with TB and diabetes. Methods: The research comprised 276 TB patients, 52 of whom were diabetic and 224 of whom were not. During the evaluation of the patients’ clinical histories, age, gender, diagnostic indicator, and whether or not they had undergone prior treatment were questioned, as were the requirement of inpatient treatment and the existence of drug resistance. Radiographically, they were questioned in terms of bilateral–unilateral extent, percentage of parenchymal involvement, cavitation, tree-in-bud appearance, the presence of ground glass, consolidation, miliary involvement, sequela fibrotic changes, parenchymal calcification, mediastinal lymphadenopathy, pleural effusion, and pleural calcification. In addition, segmenting was used to assess involvement in the affected lobes. Results: When we look at the results of 276 patients, 182 males and 94 females, the mean age is 46.01 ± 17.83. Diabetes and TB coexistence are more prevalent in male individuals (P = 0.029). Smear positivity and the need for inpatient treatment were found to be higher in the clinical features of diabetic patients (P = 0.05 and P = 0.01, respectively). Radiologically, diabetes individuals are more likely to have larger mediastinal lymph nodes (P = 0.032). Conclusion: In the coexistence of both TB and diabetes, there are variations in radiological findings, complexity in treatment response, and patient management.